September 5th 2024
Payers must continue to assess their prior authorization practices to uphold the goals of clinical quality, safety, and utilization management.
September 3rd 2024
Abolishing Coinsurance for Oral Antihyperglycemic Agents: Effects on Social Insurance Budgets
A coinsurance rate decrease can result in increased adherence to oral antihyperglycemic agents and improved clinical outcomes and cost savings for the healthcare system.
Read More